Advertisements




Silverstein, Taconic unveil pre-built wet lab at Hudson Research Center

Silverstein Properties and Taconic Investment Partners, joint venture owners of 619 West 54th Street, ha.....»»

Category: realestateSource: realestateweeklyOct 3rd, 2018

N.J. biotech firm expanding to Philadelphia, creating 200 new jobs

In another boost to Philadelphia’s standing as a cell and gene therapy hub, Cranbury, New Jersey-based Amicus Therapeutics said Tuesday it is establishing a new global research and gene therapy center at uCity Square, where the company expects t.....»»

Category: topSource: bizjournalsFeb 26th, 2019

Temple-backed biotech firm aimed at knocking out HIV raises $60M

The company's co-founder is director of the neurosciences department and center for neurovirology at the Lewis Katz School of Medicine at Temple......»»

Category: topSource: bizjournalsFeb 17th, 2021

Walker & Dunlop structures $205M in financing for Hudson Research Center

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2021

Cancer research biotech ImmunSYS files for bankruptcy

The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments......»»

Category: topSource: bizjournalsJan 7th, 2021

Genprex strikes deal with MD Anderson Cancer Center, adds to momentum in cancer fight

Genprex Inc. had a big week on Wall Street after sealing a deal with MD Anderson Cancer Center to advance research and development efforts. It was the latest piece of big news for a firm that has r.....»»

Category: topSource: bizjournalsMay 8th, 2020

Private equity firm, Blue Wolf Capital Partners inked to 3 WTC

Silverstein Properties has announced that Blue Wolf Capital Partners LLC (“Blue Wolf”), a leading private equity firm, signed a 10-year lease for approximately 20,000 square-feet at 3 World Trade Center in Downtown Manhattan.  Currently located a.....»»

Category: realestateSource: realestateweeklyFeb 20th, 2020

Biotech company doubles space in Phoenix, ramps up hiring after IPO

Though headquartered in the Houston area, the biotech firm has major growth in mind in the Valley where its research facilities are located after going public in 2019......»»

Category: topSource: bizjournalsJan 15th, 2020

Photos: Global tech firm opens first medical robotics research hub in Texas Medical Center

Switzerland-based ABB (NYSE: ABB), which has a large presence in Houston, opened a new health care robotics research facility in the Texas Medical Center on Oct. 9. The global tech group's 5,300-square-foot lab is inside of the TMC Innovation Insti.....»»

Category: topSource: bizjournalsOct 10th, 2019

CBRE brokers new lease at 3WTC

Silverstein Properties announced that Harper + Scott, a design firm, has signed a 17,456 s/flease on the 40th floor of 3 World Trade Center. Currently located at 915 Broadway in the Flatiron District, the firm will move into.....»»

Category: realestateSource: realestateweeklyOct 8th, 2019

Roswell Park partners with biotech firm to develop immunotherapy treatment

Roswell Park Comprehensive Cancer Center is partnering with a San Diego firm to develop a new way to see and treat cancer tumors. Researchers are working with OncoSec Medical Inc. (NASDAQ: ONCS) to develop a system to for using intravital microsco.....»»

Category: topSource: bizjournalsJun 18th, 2019

Adaptive Biotechnologies files for $230M initial public offering

The Seattle-based biotech company spun out of the Fred Hutchinson Cancer Research Center in 2009 and has independently raised more than $400 million in funding......»»

Category: topSource: bizjournalsMay 30th, 2019

Biotech entrepreneur seeks approval of 80-acre Triad R&D campus with 1,600 jobs

An 80.5-acre plot of land in High Point will become a hive for clinical research and pharmaceutical development if a proposal approved by the city’s Planning and Zoning Commission passes muster with the City Council.  The Oasis Center is the l.....»»

Category: topSource: bizjournalsMay 29th, 2019

The CEO of a German AI firm explains why young talent would rather work for him than for Google

Wikimedia Commons The "war for talent" on the US West Coast has led large corporations to recruit on a global scale. The CEO of the German Research Center for Artificial Inte.....»»

Category: topSource: businessinsiderApr 30th, 2018

Pillar to create driverless vehicle lab as Kasich declares Ohio a testbed for this tech

Pillar Technology LLC is developing an driverless vehicle research center that will create 25 jobs, with support from a $2 million JobsOhio economic development grant. The Columbus innovation consultant and software development firm – and severa.....»»

Category: topSource: bizjournalsMay 9th, 2018

The cradle of biotech: Companies and people that made Mass. into the world"s biotech hub

In recent years, Greater Boston has been recognized as the world’s center for biotechnology research and development. The following stories (see links below) aim to describe how that well-earned reputation came to be — through both the longtime.....»»

Category: topSource: bizjournalsMay 31st, 2018

One of the world"s largest tobacco giants is teaming up with Snoop Dogg"s VC firm to invest in medical cannabis research

Imperial Brands' venture arm invested in Oxford Cannabinoid Technologies, a UK-based biotech company, along with Casa Verde Capital. Oxford Cannabinoid Technologies is researchin.....»»

Category: topSource: businessinsiderJun 28th, 2018

New York"s Latest Real Estate Surge Takes on a Life of Its Own: Biomedical Research

A rendering of the new Hudson Research Center space,.....»»

Category: worldSource: nytJul 23rd, 2018

Report: Merck invested in Moderna at $18B valuation

Drug giant Merck & Co. valued biotech unicorn Moderna Therapeutics at $18 billion when it invested in the Cambridge-based company earlier this year, according to data from market research firm PitchBook. Moderna declined to comment on the report, which c.....»»

Category: topSource: bizjournalsAug 17th, 2018

Biotech firm raises $54M to hunt for cancer drugs

Gotham Therapeutics, a Manhattan-based biotech company, has received $54 million in Series A financing to advance research into a novel method of finding oncology drug candidates. The research was... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkOct 10th, 2018